Abiopharma

KalVista Pharmaceuticals Provides Operational Update and Reports Third Quarter Financial Results

Xtant Medical Reports Third Quarter 2025 Financial Results

Crinetics Pharmaceuticals Announces November 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Westlake Corporation Announces Pricing of Cash Tender Offer for Its 3.600% Senior Notes Due 2026

ProKidney Reports Third Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates

Passage Bio Reports Third Quarter 2025 Financial Results and Provides Recent Business Highlights

Tonix Pharmaceuticals Reports Third Quarter 2025 Financial Results and Operational Highlights

Assertio Holdings, Inc. - Assertio Reports Third Quarter 2025 Financial Results

Assertio Reports Third Quarter 2025 Financial Results

Mereo Reports Third Quarter 2025 Financial Results and Provides Corporate Highlights